Search
Vaxcyte Inc
PCVXAdd to Watchlist
59.020USD
+0.100+0.17%
Close 09-22 16:00（ET）
8.52BMarket Cap
LossP/E TTM
Vaxcyte Inc (PCVX) Stock Price Target & Forecast
Analyst Rating
Based on 11 analysts giving stock ratings to Vaxcyte Inc in the past month.
Buy
5 Strong Buy
5 Buy
1 Hold
0 Sell
0 Strong Sell
Target Price
109.000USD+87.51%
PCVX Analyst Recommendation Trends
In the current month, PCVX has received 5 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. PCVX average Analyst price target in the last month is 109.000.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
1
1
1
1
1
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
11
11
11
11
11
11
11
11
Financial Forecasting
Based on analysts' estimates, PCVX EPS is projected to reach -2.133 in FY2026Q3, following reported EPS of -1.968 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-1.52
-1.75
-2.06
-2.13
-2.04
Actual
-1.81
-2.30
-1.97
--
--
Surprise
-19.22%
-31.22%
+4.28%
--
--
FAQs
What is Vaxcyte Inc's price target?
Analysts forecast that Vaxcyte Inc's price target is USD 103.00, with the highest forecast at USD 160.00 and the lowest forecast at USD 38.00.
How have Vaxcyte IncPCVX's recent earnings per share performed?
The market expectation was USD -1.97, while Vaxcyte IncPCVX's earnings per share (EPS) for the previous quarter was USD -2.30. EPS for the next quarter is expected at USD -2.13.
What is the analyst rating for Vaxcyte Inc?
Based on the ratings of Vaxcyte Inc's stock from 11 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.